Related Experiment Videos
All-trans-retinoic acid inhibits Jun N-terminal kinase by increasing dual-specificity phosphatase activity
1Departments of Thoracic/Head and Neck Medical Oncology, University of Texas- M. D. Anderson Cancer Center, Houston, Texas 77030, USA.
Abstract:
Jun N-terminal kinases (JNKs) are serine-threonine kinases that play a critical role in the regulation of cell growth and differentiation. We previously observed that JNK activity is suppressed by all-trans-retinoic acid (t-RA), a ligand for retinoic acid nuclear receptors (RARs), in normal human bronchial epithelial cells, which are growth inhibited by t-RA. In this study, we investigated the mechanism by which t-RA inhibits JNK and the possibility that this signaling event is blocked in non-small cell lung cancer (NSCLC) cells. Virtually all NSCLC cell lines are resistant to the growth-inhibitory effects of t-RA, and a subset of them have a transcriptional defect specific to retinoid nuclear receptors. We found that in NSCLC cells expressing functional retinoid receptors, serum-induced JNK phosphorylation and activity were inhibited by t-RA in a bimodal pattern, transiently within 30 min and in a sustained fashion beginning at 12 h. Retinoid receptor transcriptional activation was required for the late, but not the early, suppression of JNK activity. t-RA inhibited serum-induced JNK activity by blocking mitogen-activated protein (MAP) kinase kinase 4-induced signaling events. This effect of t-RA was phosphatase dependent and involved an increase in the expression of the dual-specificity MAP kinase phosphatase 1 (MKP-1). t-RA did not activate MKP-1 expression or inhibit JNK activity in a NSCLC cell line with retinoid receptors that are refractory to ligand-induced transcriptional activation. These findings provide the first evidence that t-RA suppresses JNK activity by inhibiting JNK phosphorylation. Retinoid receptor transcriptional activation was necessary for the sustained inhibition of JNK activity by t-RA, and this signaling event was disrupted in NSCLC cells with retinoid receptors that are refractory to ligand-induced transcriptional activation.
Insights
All-trans-retinoic acid (t-RA) suppresses Jun N-terminal kinase (JNK) activity in normal cells. This JNK inhibition is disrupted in non-small cell lung cancer (NSCLC) cells due to defective retinoid receptors.
Area of Science:
- Cellular signaling
- Molecular biology
- Cancer research
Background:
- Jun N-terminal kinases (JNKs) regulate cell growth and differentiation.
- All-trans-retinoic acid (t-RA) inhibits JNK activity in normal bronchial cells.
- Non-small cell lung cancer (NSCLC) cells often resist t-RA's growth-inhibitory effects.
Purpose of the Study:
- Investigate the mechanism of t-RA-mediated JNK inhibition.
- Determine if this signaling is impaired in NSCLC.
- Identify the role of retinoid receptors in t-RA's effect on JNK.
Main Methods:
- Utilized NSCLC cell lines with varying retinoid receptor functionality.
- Assessed JNK phosphorylation and activity following t-RA treatment.
- Measured mitogen-activated protein kinase kinase 4 (MKK4) signaling and dual-specificity MAP kinase phosphatase 1 (MKP-1) expression.
Main Results:
- t-RA inhibited serum-induced JNK phosphorylation and activity in NSCLC cells with functional retinoid receptors in a bimodal pattern (early and late phases).
- Retinoid receptor transcriptional activation was essential for the sustained (late) JNK inhibition.
- t-RA's effect involved blocking MKK4 signaling, phosphatase dependence, and increased MKP-1 expression, which was absent in NSCLC cells with refractory retinoid receptors.
Conclusions:
- t-RA suppresses JNK activity by inhibiting JNK phosphorylation.
- Sustained JNK inhibition by t-RA requires retinoid receptor transcriptional activation.
- This signaling pathway is disrupted in NSCLC cells with refractory retinoid receptors, explaining resistance to t-RA.